Zobrazeno 1 - 10
of 186
pro vyhledávání: '"Jw, Nortier"'
Autor:
Judith Kroep, Sc, Linn, Boven E, Hj, Bloemendal, Baas J, Ia, Mandjes, van den Bosch J, Wm, Smit, de Graaf H, Cp, Schröder, Gj, Vermeulen, Wc, Hop, Jw, Nortier
Publikováno v:
Europe PubMed Central
Lapatinib, a tyrosine kinase inhibitor of human epidermal growth factor receptor 2 (HER2), has shown activity in combination with capecitabine in patients with HER2-positive advanced breast cancer progressive on standard treatment regimens. We presen
Autor:
Struikmans H, Jw, Nortier, Ej, Rutgers, Hm, Zonderland, Bontenbal M, Ph, Elkhuizen, van Tienhoven G, Vc, Tjan-Heijnen, van Vegchel T, Mariska Tuut, Benraadt J
Publikováno v:
Europe PubMed Central
The Dutch evidence-based guideline 'Treatment of breast cancer' has been revised, and integrated with the guideline 'Screening for and diagnosis of breast cancer'. The guideline can be found on www. oncoline.nl and on www.cbo.nl. The Internet program
Publikováno v:
Europe PubMed Central
Four women were referred to the department ofGynaecology for fertility preservation. A 33-year-old nulliparous woman with breast cancer stage pT1cN0M0 underwent an IVF-ICSI cycle; five embryos were frozen. Pre-implantation genetic diagnosis (PGD) bec
Publikováno v:
Europe PubMed Central
Publikováno v:
Europe PubMed Central
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::3c0716682020065e45693abf79fab882
http://europepmc.org/abstract/med/19687524
http://europepmc.org/abstract/med/19687524
Publikováno v:
Europe PubMed Central
A 37-year-old woman presented with an epidermal growth factor-(EGFR)-negative rectum carcinoma with liver metastases. After extensive treatment, consisting of first-line chemotherapy, low anterior resection, isolated liver perfusion, second- and thir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::6c0f0bb6d096fc69663d529be44013ef
http://europepmc.org/abstract/med/17152334
http://europepmc.org/abstract/med/17152334
Publikováno v:
Europe PubMed Central
Desmoid tumours (DT) are slow-growing tumours that consist of proliferations of well-differentiated fibroblasts. Although the typical characteristics of malignant tumours, such as distant metastases, are absent, the tumours are locally aggressive and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::678eef61a981337a42659998afd2b7a5
http://europepmc.org/abstract/med/12162172
http://europepmc.org/abstract/med/12162172
Autor:
Fontein DB; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands., Charehbili A; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands; Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: a.charehbili@lumc.nl., Nortier JW; Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Putter H; Department of Medical Statistics, Leiden University Medical Center, Leiden, The Netherlands., Kranenbarg EM; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands., Kroep JR; Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Linn SC; Department of Medical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., van de Velde CJ; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands.
Publikováno v:
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology [Eur J Surg Oncol] 2017 Apr; Vol. 43 (4), pp. 619-624. Date of Electronic Publication: 2016 Dec 10.
Autor:
Wapnir IL; NRG Oncology, Department of Surgery, Stanford University School of Medicine, Stanford, CA, USA. wapnir@stanford.edu., Gelber S; IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, and Frontier Science and Technology Research Foundation, Boston, MA, USA., Anderson SJ; NRG Oncology and Department of Biostatistics, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, USA., Mamounas EP; NRG Oncology and University of Florida Health Cancer Center at Orlando Health, Orlando, FL, USA., Robidoux A; NRG Oncology and Centre Hospitalier de l'Universite de Montreal, Montreal, QC, Canada., Martín M; GEICAM, Instituto de Investigacion SanitariaGregorio Marañon, Universidad Complutense, Madrid, Spain., Nortier JW; BOOG, Dutch Breast Cancer Trialists' Group, Leids Universitair Medisch Centrum, Leiden, Netherlands., Geyer CE Jr; NRG Oncology and Virginia Commonwealth University Massey Cancer Center, Richmond, VA, USA., Paterson AH; NRG Oncology and Tom Baker Cancer Centre, Calgary, Alberta, Canada., Láng I; IBCSG and National Institute of Oncology, Budapest, Hungary., Price KN; IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, and Frontier Science and Technology Research Foundation, Boston, MA, USA., Coates AS; IBCSG, Bern, Switzerland and University of Sydney, Sydney, Australia., Gelber RD; IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard TH Chan School of Public Health, Harvard Medical School, and Frontier Science and Technology Research Foundation, Boston, MA, USA., Rastogi P; NRG Oncology, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA., Regan MM; IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Wolmark N; NRG Oncology and the Allegheny Health Network Cancer Institute, Pittsburgh, PA, USA., Aebi S; IBCSG, Luzerner Kantonsspital, Lucerne and University of Berne, Switzerland and Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland.
Publikováno v:
Annals of surgical oncology [Ann Surg Oncol] 2017 Feb; Vol. 24 (2), pp. 398-406. Date of Electronic Publication: 2016 Sep 23.
Autor:
Komen MM; Department of Internal Medicine and Medical Oncology, Medical Centre Alkmaar, PO Box 501, 1800, AM, Alkmaar, The Netherlands. manon.komen@mca.nl., Breed WP; Give Hair a Chance Foundation, Research Department, Knowledge Institute Scalp Cooling, PO Box 231, 5600, AE, Eindhoven, The Netherlands., Smorenburg CH; Department of Medical Oncology, Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066, CX, Amsterdam, The Netherlands., van der Ploeg T; Science Department, Medical Centre Alkmaar, PO Box 501, 1800, AM, Alkmaar, The Netherlands., Goey SH; Department of Internal Medicine, Twee Steden ziekenhuis, Dr. Deelenlaan 5, 5042, AD, Tilburg, The Netherlands., van der Hoeven JJ; Department of Medical Oncology, Leiden University Medical Centre, PO Box 9600, 2300, RC, Leiden, The Netherlands., Nortier JW; Department of Medical Oncology, Leiden University Medical Centre, PO Box 9600, 2300, RC, Leiden, The Netherlands., van den Hurk CJ; Research Department, The Netherlands Comprehensive Cancer Organisation, PO Box 231, 5600, AE, Eindhoven, The Netherlands.
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2016 Jun; Vol. 24 (6), pp. 2735-41. Date of Electronic Publication: 2016 Jan 25.